Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fecal Microbiota Transplantation for IBS
Sponsor: Madhusudan (Madhu) Grover, MBBS
Summary
The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with irritable bowel syndrome (IBS) and high proteolytic activity. Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids.
Official title: Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)
Key Details
Gender
FEMALE
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
43
Start Date
2024-04-15
Completion Date
2026-12
Last Updated
2025-10-24
Healthy Volunteers
No
Conditions
Interventions
Donor Fecal Microbiota Transplantation
Single fecal microbiota transplantation using 50 gm of freeze-thawed donor stool
Autologous Fecal Microbiota Transplantation
Single fecal microbiota transplantation using 50 gm of stool collected from the same individual
Locations (1)
Mayo Clinic in Minnesota
Rochester, Minnesota, United States